Skip to main content
SpringerLink
Log in

Lipid peroxides, superoxide dismutase and circulating IL-8 and GCP-2 in patients with severe obstructive sleep apnea: a pilot study

  • Original Article
  • Published:
Sleep and Breathing Aims and scope Submit manuscript

Abstract

Obstructive sleep apnea (OSA) is associated with cardiovascular morbidity and mortality and many other physiological and immunological disorders. An increase in hypoxia due to OSA may cause generation of reactive oxygen species (ROS). ROS are toxic to biomembranes and may lead to peroxidation of lipids. An increase in systemic biomarkers of inflammation and oxidative stress has been found in patients with OSA. The first aim of this study was to test the hypothesis that OSA is linked to increased oxidative stress (lipid peroxidation) and decreased antioxidant defense [superoxide dismutase (SOD)]. The second aim was to measure the serum levels of neutrophil chemokines [interleukin-8 (IL-8)], and granulocyte chemotactic protein-2 (GCP-2) in OSA patients. Twenty five patients with severe OSA and 17 healthy subjects were recruited. IL-8 and GCP-2 were measured in the serum by a specific enzyme immunoassay kit. Oxidative stress level was quantitated by measurement of thiobarbituric acid reactive substances. SOD enzymatic activity was measured by purely chemical system based on NAD(P)H oxidation. Mean SOD and lipid peroxidation concentrations of patients were not significantly different from those of control subjects (0.29±0.015 vs 0.31±0.01 U/ml and 4.64±0.57 vs 4.62±0.54 mmol/ml, respectively). Higher concentrations of IL-8 and GCP-2 were found in OSA patients (198.8±4.76 vs 180.83±3.38 and 383.34±46.19 vs 218±13.16 pg/ml, respectively, p<0.005). The present study does not support the hypothesis that OSA is linked to increased oxidative stress and decreased antioxidant defense. On the other hand, it suggests that systemic inflammation characterizes OSA patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. American Academy of Sleep Medicine Task Force (1999) Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 22:667–689

    Google Scholar 

  2. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328:1230–1235

    Article  PubMed  CAS  Google Scholar 

  3. Lattimore JD, Celermajer DS, Wilcox I (2003) Obstructive sleep apnea and cardiovascular disease. J Am Coll Cardiol 41:1429–1437

    Article  PubMed  Google Scholar 

  4. Pepperell JC, Davies RJ, Stradling JR (2002) Systemic hypertension and obstructive sleep apnea. Sleep Med Rev 3:157–173

    Article  Google Scholar 

  5. Shamsuzzaman AS, Gersh BJ, Somers VK (2003) Obstructive sleep apnea, implication for cardiac and vascular disease. JAMA 290:1906–1914

    Article  PubMed  CAS  Google Scholar 

  6. Wolk R (2003) Sleep-disordered breathing and cardiovascular disease. Circulation 108:9–12

    Article  PubMed  Google Scholar 

  7. Leung RS, Bradley TD (2001) Sleep apnea and cardiovascular disease. Am J Respir Crit Care Med 164:2147–2165

    PubMed  CAS  Google Scholar 

  8. Lavie P, Herer P, Hoffstein V (2000) Obstructive sleep apnea syndrome as a risk factor for hypertension: population study. BMJ 320:479–482

    Article  PubMed  CAS  Google Scholar 

  9. Grote L, Hedner J, Peter JH (2000) Sleep related-breathing disorder is independent factor for uncontrolled hypertension. J Hypertens 18:679–685

    Article  PubMed  CAS  Google Scholar 

  10. Gerszten RE, Garcia-Zepeda EA, Lim YC, Yoshida M, Ding HA, Gimbrone MA Jr, Luster AD et al (1999) MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398:718–723

    Article  PubMed  CAS  Google Scholar 

  11. Haught WH, Mansour M, Rothlein R, Kishimoto TK, Mainolfi EA, Hendricks JB, Hendricks C, Mehta JL (1996) Alterations in circulating intercellular adhesion molecule-1 and L-selectin: further evidence for chronic inflammation in ischemic heart disease. Am Heart J 132:1–8

    Article  PubMed  CAS  Google Scholar 

  12. Simonini A, Moscucci M, Muller DW, Bates ER, Pagani FD, Burdick MD, Strieter RM (2000) IL-8 is an angiogenic factor in human coronary atherectomy tissue. Circulation 101:1519–1526

    PubMed  CAS  Google Scholar 

  13. Luster AD (1998) Chemokines—chemotactic cytokines that mediate inflammation. N Engl J Med 338:436–445

    Article  PubMed  CAS  Google Scholar 

  14. Wuyts A, Proost P (1998) Interleukin-8 and other CXC chemokines. In: Thomson A (ed) The cytokine handbook. Academic Press, San Diego, pp 272–302

    Google Scholar 

  15. Green SP, Chuntharapai A, Curnutte JT (1996) Interleukin-8 (IL-8), melanoma growth-stimulatory activity, and neutrophil-activating peptide selectively mediate priming of the neutrophil NADPH oxidase through the type A or type B IL-8 receptor. J Biol Chem 271(41):25400–25405

    Article  PubMed  CAS  Google Scholar 

  16. Ahuja SK, Murphy PM (1996) The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. J Biol Chem 271(34):20545–20550

    Article  PubMed  CAS  Google Scholar 

  17. Van Damme J, Wuyts A, Froyen G, Van Coillie E, Struyf S, Billiau A, Proost P, Wang JM, Opdenakker G (1997) Granulocyte chemotactic protein-2 and related CXC chemokines: from gene regulation to receptor usage. J Leukoc Biol 62(5):563–569

    PubMed  Google Scholar 

  18. Feniger-Barish R, Belkin D, Zaslaver A, Gal S, Dori M, Ran M, Ben-Baruch A (2000) GCP-2-induced internalization of IL-8 receptors: hierarchical relationships between GCP-2 and other ELR(+)-CXC chemokines and mechanisms regulating CXCR2 internalization and recycling. Blood 95(5):1551–1559

    PubMed  CAS  Google Scholar 

  19. Ohga E, Tomita T, Wada H, Yamamoto H, Nagase T, Ouchi Y (2003) Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. J Appl Physiol 94:179–184

    PubMed  CAS  Google Scholar 

  20. Boring L, Gosling J, Cleary M, Charo IF (1998) Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394:894–897

    Article  PubMed  CAS  Google Scholar 

  21. Halliwell B (1993) The role of oxygen radical in human disease, with particular reference to the vascular system. Haemostasis 23:118–126

    PubMed  CAS  Google Scholar 

  22. Muge A (1998) The role of reactive oxygen species in atherosclerosis. Z Kardiol 87:851–854

    Article  PubMed  Google Scholar 

  23. Duranteau J, Chandel NS, Kulisz A, Shao Z, Schumacker PT (1998) Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes. J Biol Chem 273:11619–11624

    Article  PubMed  CAS  Google Scholar 

  24. Lavie L (2002) Obstructive sleep apnea syndrome—an oxidative stress disorder. Sleep Med 7(1):35–51

    Article  Google Scholar 

  25. Wali SO, Bahammam AS, Massaeli H, Pierce GN, Iliskovic N, Singal PK, Kryger MH (1998) Susceptibility of LDL to oxidative stress in obstructive sleep apnea. Sleep 1(21):290–296

    Google Scholar 

  26. Ozturk L, Mansour B, Yuksel M, Yalcin AS, Celikoglu F, Gokhan N (2003) Lipid peroxidation and osmotic fragility of red blood cells in sleep-apnea patients. Clin Chim Acta 332:83–88

    Article  PubMed  CAS  Google Scholar 

  27. Lavie L, Vishnevsky A, Lavie P (2004) Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 27:123–128

    PubMed  Google Scholar 

  28. Barcelo A, Miralles C, Barbe F, Vila M, Pons S, Agusti AG (2000) Abnormal lipid peroxidation in patients with sleep apnoea. Eur Respir J 6:644–647

    Article  Google Scholar 

  29. Jentzsch AM, Bachmann H, Furst P, Biesalski HK (1996) Improved analysis of malondialdehyde in human body fluids. Free Radic Biol Med 20:251–256

    Article  PubMed  CAS  Google Scholar 

  30. Paoletti F, Mocali A (1990) Determination of superoxide dismutase activity by purely chemical system based on NAD(P)H oxidation. Methods Enzymol 186:209–220

    PubMed  CAS  Google Scholar 

  31. Rechtschaffen A, Kales A (eds) (1968) A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. NIH Publication number 204, US Government Printing Office, Washington

    Google Scholar 

  32. American Sleep Disorders Association, Atlas Task Force (1992) EEG arousals: scoring rules and examples. Sleep 15:174–184

    Google Scholar 

  33. Peppard PE, Young T, Palta M, Skatrud J (2000) Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342:1378–1384

    Article  PubMed  CAS  Google Scholar 

  34. Wolk R, Shamsuzzaman AS, Somers VK (2003) Obesity, sleep apnea, and hypertension. Hypertension 42:1067–1074

    Article  PubMed  CAS  Google Scholar 

  35. Phillips BG, Somers VK (2003) Hypertension and obstructive sleep apnea. Curr Hypertens Rep 5:380–385

    Article  PubMed  Google Scholar 

  36. Sharabi Y, Dagan Y, Grossman E (2004) Sleep apnea as a risk factor for hypertension. Curr Opin Nephrol Hypertens 13:359–364

    Article  PubMed  Google Scholar 

  37. Wolk R, Kara T, Somers VK (2003) Sleep-disordered breathing and cardiovascular disease. Circulation 108(1):9–12

    Article  PubMed  Google Scholar 

  38. Leung RS, Bradley TD (2001) Sleep apnea and cardiovascular disease. Am J Respir Crit Care Med 164(12):2147–2165

    PubMed  CAS  Google Scholar 

  39. Christou K, Moulas AN, Pastaka C, Gourgoulianis KI (2003) Antioxidant capacity in obstructive sleep apnea patients. Sleep Med 4(3):225–228

    Article  PubMed  Google Scholar 

  40. Christou K, Markoulis N, Moulas AN, Pastaka C, Gourgoulianis KI (2003) Reactive oxygen metabolites (ROMs) as an index of oxidative stress in obstructive sleep apnea patients. Sleep Breath 7:105–110

    Article  PubMed  Google Scholar 

  41. Carpagnano GE, Kharitonov SA, Resta O, Foschino-Barbaro MP, Gramiccioni E, Barnes PJ (2002) Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients. Chest 122:1162–1167

    Article  PubMed  CAS  Google Scholar 

  42. Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K, Chrousos GP (1997) Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 82:1313–1316

    Article  PubMed  CAS  Google Scholar 

  43. Vgontzas AN, Bixler EO, Papanicolaou DA, Chrousos GP (2000) Chronic systemic inflammation in overweight and obese adults. JAMA 283(17):2235; author reply 2236

    Article  PubMed  CAS  Google Scholar 

  44. Schulz R, Mahmoudi S, Hattar K, Sibelius U, Olschewski H, Mayer K, Seeger W, Grimminger F (2000) Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 162(2 Pt 1):566–570

    PubMed  CAS  Google Scholar 

  45. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP (1998) The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 128(2):127–137

    PubMed  CAS  Google Scholar 

  46. Dinarello CA (1997) Role of pro- and anti-inflammatory cytokines during inflammation: experimental and clinical findings. J Biol Regul Homeost Agents 11(3):91–103

    PubMed  CAS  Google Scholar 

  47. Vgontzas AN, Papanicolaou DA, Bixler EO, Lotsikas A, Zachman K, Kales A, Prolo P et al (1999) Circadian interleukin-6 secretion and quantity and depth of sleep. J Clin Endocrinol Metab 84:2603–2607

    Article  PubMed  CAS  Google Scholar 

  48. Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin HM, Kales A, Chrousos GP (2000) Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 85:1151–1158

    Article  PubMed  CAS  Google Scholar 

  49. Dyugovskaya L, Lavie P, Lavie L (2002) Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 165:934–939

    PubMed  Google Scholar 

  50. Strohl KP (1996) Tumor necrosis factor and sleep apnea. Am J Respir Crit Care Med 153:893

    PubMed  CAS  Google Scholar 

  51. Castell JV, Gomez-Lechon MJ, David M, Fabra R, Trullenque R, Heinrich PC (1990) Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology 12(5):1179–1186

    Article  PubMed  CAS  Google Scholar 

  52. Shamsuzzaman AS, Winnicki M, Lanfranchi P, Wolk R, Kara T, Accurso V, Somers VK (2002) Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105(21):2462–2464

    Article  PubMed  CAS  Google Scholar 

  53. Ku NO, Mortensen RF (1993) The mouse C-reactive protein (CRP) gene is expressed in response to IL-1 but not IL-6. Cytokine 5(4):319–326

    Article  PubMed  CAS  Google Scholar 

  54. Khreiss T, Jozsef L, Potempa LA, Filep JG (2004) Opposing effects of C-reactive protein isoforms on shear-induced neutrophil-platelet adhesion and neutrophil aggregation in whole blood. Circulation 110(17):2713–2720

    Article  PubMed  CAS  Google Scholar 

  55. Devaraj S, Xu DY, Jialal I (2003) C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation 107(3):398–404

    Article  PubMed  CAS  Google Scholar 

  56. Ben-Baruch A, Michiel DF, Oppenheim JJ (1995) Signals and receptors involved in recruitment of inflammatory cells. J Biol Chem 270(20):11703–11706

    Article  PubMed  CAS  Google Scholar 

  57. Ben-Baruch A, Bengali KM, Biragyn A, Johnston JJ, Wang JM, Kim J, Chuntharapai A, Michiel DF, Oppenheim JJ, Kelvin DJ (1995) Interleukin-8 receptor beta. The role of the carboxyl terminus in signal transduction. J Biol Chem 270(16):9121–9128

    Article  PubMed  CAS  Google Scholar 

  58. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, Kannel WB, Vasan RS (2002) Obesity and the risk of heart failure. N Engl J Med 347(5):305–313

    Article  PubMed  Google Scholar 

  59. Bruun JM, Pedersen SB, Richelsen B (2000) Interleukin-8 production in human adipose tissue. Inhibitory effects of anti-diabetic compounds, the thiazolidinedione ciglitazone and the biguanide metformin. Horm Metab Res 32(11–12):537–541

    Article  PubMed  CAS  Google Scholar 

  60. Bruun JM, Pedersen SB, Richelsen B (2001) Regulation of interleukin 8 production and gene expression in human adipose tissue in vitro. J Clin Endocrinol Metab 86(3):1267–1273

    Article  PubMed  CAS  Google Scholar 

  61. Straczkowski M, Dzienis-Straczkowska S, Stepien A, Kowalska I, Szelachowska M, Kinalska I (2002) Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-alpha system. J Clin Endocrinol Metab 87(10):4602–4606

    Article  PubMed  CAS  Google Scholar 

  62. Krabbe KS, Bruunsgaard H, Hansen CM, Moller K, Fonsmark L, Qvist J, Madsen PL et al (2001) Ageing is associated with a prolonged fever response in human endotoxemia. Clin Diagn Lab Immunol 8:333–338

    Article  PubMed  CAS  Google Scholar 

  63. Marik PE, Zaloga GP, NORASEPT II Study Investigators, North American Sepsis Trial II (2001) The effect of aging on circulating levels of proinflammatory cytokines during septic shock. Norasept II study investigators. J Am Geriatr Soc 49:5–9

    Article  PubMed  CAS  Google Scholar 

  64. Gon Y, Hashimoto S, Hayashi S, Koura T, Matsumoto K, Horie T (1996) Lower serum concentrations of cytokines in elderly patients with pneumonia and the impaired production of cytokines by peripheral blood monocytes in the elderly. Clin Exp Immunol 106(1):120–126

    PubMed  CAS  Google Scholar 

  65. Wei J, Xu H, Davies JL, Hemmings GP (1992) Increase of plasma IL-6 concentration with age in healthy subjects. Life Sci 51(25):1953–1956

    Article  PubMed  CAS  Google Scholar 

  66. Ershler WB (1993) Interleukin-6: a cytokine for gerontologists. J Am Geriatr Soc 41(2):176–181

    PubMed  CAS  Google Scholar 

  67. Bruunsgaard H, Andersen-Ranberg K, Jeune B, Pedersen AN, Skinhoj P, Pedersen BK (1999) A high plasma concentration of TNF-alpha is associated with dementia in centenarians. J Gerontol A Biol Sci Med Sci 54(7):M357–M364

    PubMed  CAS  Google Scholar 

  68. Hager K, Machein U, Krieger S, Platt D, Seefried G, Bauer J (1994) Interleukin-6 and selected plasma proteins in healthy persons of different ages. Neurobiol Aging 15(6):771–772

    Article  PubMed  CAS  Google Scholar 

  69. Paolisso G, Rizzo MR, Mazziotti G, Tagliamonte MR, Gambardella A, Rotondi M, Carella C, Giugliano D, Varricchio M, D’Onofrio F (1998) Advancing age and insulin resistance: role of plasma tumor necrosis factor-alpha. Am J Physiol 275(2 Pt 1):E294–E299

    PubMed  CAS  Google Scholar 

  70. Krabbe KS, Pedersen M, Bruunsgaard H (2004) Inflammatory mediators in the elderly. Exp Gerontol 39(5):687–699

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Medicine, King Saud University, P.O. Box 2925, 11461, Riyadh, Saudi Arabia

    Mohammed A. Alzoghaibi & Ahmed S. O. BaHammam

Authors
  1. Mohammed A. Alzoghaibi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ahmed S. O. BaHammam
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ahmed S. O. BaHammam.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alzoghaibi, M.A., BaHammam, A.S.O. Lipid peroxides, superoxide dismutase and circulating IL-8 and GCP-2 in patients with severe obstructive sleep apnea: a pilot study. Sleep Breath 9, 119–126 (2005). https://doi.org/10.1007/s11325-005-0022-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11325-005-0022-1

Keywords

Search

Navigation